Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

BUY
$187.54 - $223.02 $44,822 - $53,301
239 Added 5.39%
4,675 $953,000
Q1 2022

Apr 12, 2022

BUY
$193.77 - $244.14 $117,230 - $147,704
605 Added 15.79%
4,436 $934,000
Q4 2021

Jan 18, 2022

SELL
$223.92 - $287.77 $99,868 - $128,345
-446 Reduced 10.43%
3,831 $919,000
Q3 2021

Oct 18, 2021

BUY
$282.99 - $369.05 $938,960 - $1.22 Million
3,318 Added 345.99%
4,277 $1.21 Million
Q2 2021

Jul 16, 2021

BUY
$259.0 - $414.71 $248,381 - $397,706
959 New
959 $332,000
Q1 2021

Apr 09, 2021

SELL
$242.95 - $284.63 $477,639 - $559,582
-1,966 Closed
0 $0
Q4 2020

Jan 11, 2021

BUY
$236.26 - $355.63 $395,026 - $594,613
1,672 Added 568.71%
1,966 $481,000
Q3 2020

Oct 23, 2020

SELL
$264.77 - $305.71 $1.24 Million - $1.43 Million
-4,667 Reduced 94.07%
294 $83,000
Q2 2020

Jul 13, 2020

BUY
$258.66 - $342.55 $1.26 Million - $1.67 Million
4,862 Added 4911.11%
4,961 $1.5 Million
Q1 2020

Apr 14, 2020

SELL
$268.85 - $341.04 $311,059 - $394,583
-1,157 Reduced 92.12%
99 $31,000
Q4 2019

Jan 31, 2020

BUY
$220.06 - $304.07 $266,052 - $367,620
1,209 Added 2572.34%
1,256 $373,000
Q3 2019

Oct 15, 2019

SELL
$217.44 - $243.88 $466,843 - $523,610
-2,147 Reduced 97.86%
47 $10,000
Q2 2019

Jul 18, 2019

BUY
$219.29 - $241.72 $475,420 - $524,048
2,168 Added 8338.46%
2,194 $513,000
Q1 2019

Apr 11, 2019

BUY
$216.71 - $338.96 $5,634 - $8,812
26 New
26 $6,000
Q4 2018

Jan 22, 2019

SELL
$278.5 - $352.75 $217,787 - $275,850
-782 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$293.51 - $383.83 $229,231 - $299,771
781 Added 78100.0%
782 $276,000
Q2 2018

Aug 01, 2018

BUY
$257.52 - $306.91 $257 - $306
1 New
1 $0
Q1 2018

May 02, 2018

SELL
$260.13 - $367.91 $388,634 - $549,657
-1,494 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$307.64 - $344.58 $459,614 - $514,802
1,494
1,494 $476,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.